Indian Syntans, the 4.5 per cent stakeholder in Aventis CropScience India (ASCI), has appealed before the Securities Appellate Tribunal (SAT) against the Securities Exchange Board of India (Sebi) directive to Bayer CropScience AG to go ahead with its open offer for ASCI.
Senior executives at Indian Syntans said: